Citadel Advisors’s Enlivex ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-117
Closed -$21.6K – 13967
2026
Q1
$26K Buy
117
+10
+9% +$2.53K ﹤0.01% 12616
2025
Q4
$18K Sell
107
-180
-63% -$42.9K ﹤0.01% 12363
2025
Q3
$71.7K Buy
+287
New +$82.8K ﹤0.01% 12023
2025
Q2
– Sell
-292
Closed -$69.4K – 13172
2025
Q1
$68K Buy
+292
New +$77.6K ﹤0.01% 11955
2024
Q2
– Sell
-231
Closed -$98.1K – 14521
2024
Q1
$210K Buy
231
+201
+670% +$157K ﹤0.01% 10211
2023
Q4
$19.1K Sell
30
-127
-81% -$51.8K ﹤0.01% 12654
2023
Q3
$59.5K Sell
157
-4
-2% -$2.22K ﹤0.01% 11549
2023
Q2
$102K Sell
161
-45
-22% -$30.1K ﹤0.01% 10909
2023
Q1
$180K Sell
206
-42
-17% -$40.5K ﹤0.01% 10360
2022
Q4
$232K Buy
248
+83
+50% +$85.7K ﹤0.01% 9833
2022
Q3
$168K Buy
+165
New +$193K ﹤0.01% 10591
2021
Q1
– Sell
-45
Closed -$149K – 13275
2020
Q4
$91K Buy
+45
New +$116K ﹤0.01% 10275
2017
Q2
– Sell
-2
Closed -$17K – 7608
2017
Q1
$17K Buy
+2
New +$21.1K ﹤0.01% 7286
2016
Q4
– Sell
-1
Closed -$19K – 7374
2016
Q3
$19K Buy
+1
New +$16.2K ﹤0.01% 7066

Other funds holding ENLV

Citadel Advisors's ENLV Position: Q2 2026 in Review

Citadel Advisors sold out of Enlivex (ENLV) in Q2 2026, closing a stake of 117 shares — an estimated $21.6K sold.

Citadel Advisors first reported a position in ENLV in Q3 2016 and held it in 14 quarters. The position peaked at $232K in Q4 2022. 24 funds tracked by Wall St. Rank hold ENLV as of Q2 2026.

  • Citadel Advisors reported no remaining Enlivex position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 117 Enlivex shares in Q2 2026, an estimated $21.6K.
  • Citadel Advisors first reported a position in Enlivex in Q3 2016 and held it in 14 quarters.
  • Citadel Advisors's Enlivex position peaked at $232K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Enlivex as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.